Assessing Drug Epetraborole in Patients with Mycobacterium avium

Recruiting

18 years - 99 years

All

5 participants needed

1 Location

Brief description of study

The purpose of this study is to learn about the effects of a study drug, Epetraborole, to assess the efficacy for treating refractory MAC. It will enroll patients over 18 years of age and will include the following: physical exams, CTs, medical history, ECGs, lung function tests, vital signs, safety labs, PK labs, and questionnaires. Participants will be paid $50 for each study visit.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Medical Research, Mycobacterium avium Complex Lung Disease (MACrO2)
Age: 18 years - 99 years
Gender: All

Updated on 04 Aug 2024. Study ID: 851421

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Assessing Drug Epetraborole in Patients with Mycobacterium avium Complex Lung Disease (MACrO2)

Brief description of study

Eligibility of study

Find a site

Interested in the study